ASX:AT1 Atomo Diagnostics (AT1) Stock Price, News & Analysis → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free AT1 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Atomo Diagnostics alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Atomo Diagnostics Stock (ASX:AT1)Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now AT1 Stock News HeadlinesMarch 7, 2024 | msn.comTop 10 at 11: Dicker Data founder sells $90.47 million worth of stock following divorce settlementMarch 6, 2024 | msn.comASX Health Stocks: Atomo pops 90pc after purchase order; AdAlta up 20pc on Phase 1 resultsMay 6, 2024 | Lear Capital (Ad)Dollar CancelledDon’t wait to protect your hard-earned savings. Top economists and billionaires are predicting that the dollar could collapse before the end of 2024.January 17, 2024 | msn.comCheck Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C ReportJanuary 1, 2024 | msn.comASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024October 26, 2023 | finance.yahoo.comIt's Probably Less Likely That Atomo Diagnostics Limited's (ASX:AT1) CEO Will See A Huge Pay Rise This YearJuly 5, 2023 | fool.com.au3 ASX healthcare shares rocketing 20% to 100% todayJuly 4, 2023 | finance.yahoo.comCompanies Like Atomo Diagnostics (ASX:AT1) Are In A Position To Invest In GrowthMay 6, 2024 | Lear Capital (Ad)Dollar CancelledDon’t wait to protect your hard-earned savings. Top economists and billionaires are predicting that the dollar could collapse before the end of 2024.June 29, 2023 | seekingalpha.comAXDX Accelerate Diagnostics, Inc.March 7, 2023 | finance.yahoo.comGlobal COVID-19 Diagnostics Market Report 2023: Assay Volumes and 5-Year Market Size Outlook - A New Very Large Market for Diagnostics is EmergingFebruary 24, 2023 | finance.yahoo.comOutlook on the Immunoassay Global Market to 2027: by Application, Technology, Product, User and by CountryFebruary 21, 2023 | finance.yahoo.comMicrobiology Diagnostic Devices And Equipment Global Market Report 2022: Increased Funding and Worldwide Healthcare Access Bolsters SectorJanuary 1, 2023 | finance.yahoo.comWith 7.2% CAGR, US Blood Transfusion Diagnostics Market Size worth USD 3.58 Billion by 2029December 26, 2022 | nz.finance.yahoo.comWe Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business GrowthDecember 12, 2022 | finance.yahoo.comTransplant Diagnostics Market Size to Grow at 8% CAGR During the Forecast Period of 2022-2030 | Growth Plus ReportsJuly 19, 2022 | finance.yahoo.comIs Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?May 27, 2022 | finance.yahoo.comAtomo Diagnostics Limited (AT1.AX)February 21, 2022 | msn.comNegative result: Atomo Diagnostics (ASX: AT1) shares plunge 18% on half-year earningsJanuary 26, 2022 | msn.comHere’s why the Atomo (ASX:AT1) share price is rocketing 17% todayJanuary 4, 2022 | msn.comWhy has the Atomo Diagnostics (ASX: AT1) share price surged 50% since Christmas?December 30, 2021 | msn.comCheck Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pcDecember 11, 2021 | finance.yahoo.comAtomo Diagnostics (ASX:AT1 shareholders incur further losses as stock declines 15% this week, taking one-year losses to 47%October 28, 2021 | msn.comWhy is the Atomo Diagnostics (ASX:AT1) share price wobbling on Thursday?October 5, 2021 | msn.comHere’s why the Atomo (ASX:AT1) share price is crashing 9% todayOctober 4, 2021 | msn.comWhy is the Atomo Diagnostics (ASX:AT1) share price halted?October 1, 2021 | finance.yahoo.comAtomo Diagnostics Limited (ASX:AT1) Shares Could Be 36% Below Their Intrinsic Value EstimateSee More Headlines Receive AT1 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atomo Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:AT1 CUSIPN/A CIKN/A Webatomodiagnostics.com Phone61 2 9099 4750FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,370,000.00 Net Margins-237.01% Pretax MarginN/A Return on Equity-44.83% Return on Assets-24.66% Debt Debt-to-Equity Ratio1.25 Current Ratio8.69 Quick Ratio10.22 Sales & Book Value Annual Sales$3.11 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares639,200,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.00 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. John Michael KellyFounder, CEO, MD & DirectorMs. Chandra SukumarChief Operating OfficerMr. Jim P. McMenamyHead of Business Development & Partnerships of the AmericasMs. Anna TuckerHead of Business Development & Partnerships of Europe, Middle East and AfricaMs. Maria ClementeCompany SecretaryKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersJohn KellySold 666,666 sharesTotal: $19,999.98 ($0.03/share) This page (ASX:AT1) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersCould Your Accounts Be Frozen?Allegiance GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atomo Diagnostics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
